![]() |
|||||||||||||||||
![]() |
|||||||||||||||||
![]() ![]() ![]() |
![]() |
|
|||||||||||||||
![]() |
![]() |
MATERIAL SAFETY DATA SHEET - INFECTIOUS SUBSTANCES SECTION I - INFECTIOUS AGENT NAME: Haemophilus ducreyi SYNONYM OR CROSS REFERENCE: Chancroid, Ulcus molle, soft chancre; the Ducreyi bacillus CHARACTERISTICS: Gram-negative, aerobic, coccobacilli; cell wall contains lipooligosaccharide; bipolar staining; non-spore forming SECTION II - HEALTH HAZARD PATHOGENICITY: Acute bacterial infection usually localized in the genital area; characterized by single or multiple painful necrotizing ulcers in the genital area, accompanied by a painful inflammation, swelling and suppuration of regional lymph nodes (inguinal adenitis); extragenital lesions have been documented EPIDEMIOLOGY: Occurs more often in males; prevalent in tropical and subtropical regions of the world; chancroid ulcers are associated with increased risk of HIV; uncircumcised are at higher risk of infection; some endemic transmission in migrant farm workers HOST RANGE: Humans INFECTIOUS DOSE: Not known MODE OF TRANSMISSION: Direct sexual contact with discharges from open lesions and pus from buboes; auto-inoculation to non-genital sites may occur INCUBATION PERIOD: From 3 - 5 days, up to 14 days COMMUNICABILITY: Communicable until infectious agent persists in the original lesion or discharging regional lymph nodes; can last weeks to months without antibiotic treatment SECTION III - DISSEMINATION RESERVOIR: Humans ZOONOSIS: None VECTORS: None SECTION IV - VIABILITY DRUG SUSCEPTIBILITY: Susceptible to ceftriaxone, erthromycin, co-trimoxazole, azithromycin, ciprofloxacin, amoxicillin, clavulanic acid SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to 70% ethanol, 1% sodium hypochlorite, 2% glutaraldehyde, iodophor, povidone-iodine PHYSICAL INACTIVATION: 121° C for 15 minutes SURVIVAL OUTSIDE HOST: Sensitive to drying SECTION V - MEDICAL SURVEILLANCE: Monitor for symptoms; confirm bacteriologically FIRST AID/TREATMENT: Administer antibiotic therapy; fluctuant inguinal nodes should be aspirated through intact skin to prevent spontaneous rupture IMMUNIZATION: None available PROPHYLAXIS: None available SECTION VI - LABORATORY HAZARDS LABORATORY-ACQUIRED INFECTIONS: One reported by Trees et al. in 1992 SOURCES/SPECIMENS: Lesion exudates PRIMARY HAZARDS: Accidental parenteral inoculation SPECIAL HAZARDS: None SECTION VII - RECOMMENDED PRECAUTIONS CONTAINMENT REQUIREMENTS: Biosafety level 2 practices and containment facilities for all activities involving the bacteria or potentially infectious tissues and body fluids PROTECTIVE CLOTHING: Laboratory coat; gloves when skin contact with infectious materials is unavoidable OTHER PRECAUTIONS: General needle safety precautions are important; do not recap, break or bend needles; discard used needles directly into a puncture-proof container SECTION VIII - HANDLING INFORMATION SPILLS: Allow aerosols to settle; wearing protective clothing gently cover the spill with absorbent paper towel and apply 1% sodium hypochlorite, starting at the perimeter and working towards the center; allow sufficient contact time (30 min) before clean up DISPOSAL: Decontaminate all wastes before disposal; steam sterilization, chemical disinfection, incineration STORAGE: In sealed containers that are appropriately labelled SECTION IX - MISCELLANEOUS INFORMATION Date prepared: April, 2001 Prepared by: Office of Laboratory Security, PHAC Although the information, opinions and recommendations contained in this Material Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date. Copyright © [Material Safety Data Sheets - Index]
|
![]() |
|||
![]() |
Last Updated: 2001-05-25 | ![]() |